Longeveron Inc. (LGVN)
NASDAQ · Healthcare
Longeveron Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 1.2M | 2.4M | 709,000 | 1.2M | 1.3M | 5.6M |
| Gross Profit | 803,000 | 1.9M | 221,000 | 497,000 | 590,000 | 1.8M |
| Profitability | ||||||
| Operating Income | -23.3M | -16.5M | -21.0M | -18.0M | -17.5M | -3.8M |
| EBITDA | -22.5M | -15.8M | -20.3M | -17.3M | -17.5M | -3.8M |
| Net Income | -22.7M | -16.0M | -21.4M | -18.8M | -17.0M | -3.7M |
| Per Share Data | ||||||
| EPS (diluted) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | — |
| Shares Outstanding (dil.) | 17,577M | 9,411M | 2,173M | 21M | 19M | — |
Longeveron Inc. Income Statement — FAQ
Longeveron Inc. (LGVN) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LGVN's income statement history?
The chart and table above show Longeveron Inc.'s income statement by year and by quarter, including the growth rate.